These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 14872558)

  • 41. Two equally valid interpretations of the linear multicompartment mammillary pharmacokinetic model.
    Jacobs JR; Shafer SL; Larsen JL; Hawkins ED
    J Pharm Sci; 1990 Apr; 79(4):331-3. PubMed ID: 2352145
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sex-related differences in the pharmacokinetics of oral ciprofloxacin.
    Overholser BR; Kays MB; Forrest A; Sowinski KM
    J Clin Pharmacol; 2004 Sep; 44(9):1012-22. PubMed ID: 15317829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).
    Usansky HH; Sinko PJ
    J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modeling the drug transport in the anterior segment of the eye.
    Avtar R; Tandon D
    Eur J Pharm Sci; 2008 Oct; 35(3):175-82. PubMed ID: 18662774
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pharmacokinetic research on bilignost (a mathematical physiological model)].
    Manuĭlov KK
    Farmakol Toksikol; 1986; 49(3):83-6. PubMed ID: 3720940
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Midpoint back-extrapolation method for the rapid estimation of drugs' volume of distribution and dosage adjustment exhibiting multicompartmental characteristics.
    Chiou WL; Huang SM; Huang YC
    Int J Clin Pharmacol Ther Toxicol; 1980 Jan; 18(1):1-4. PubMed ID: 7364527
    [TBL] [Abstract][Full Text] [Related]  

  • 47. On nonoscillation and monotonicity of solutions of nonnegative and compartmental dynamical systems.
    Chellaboina V; Haddad WM; Bailey JM; Ramakrishnan J
    IEEE Trans Biomed Eng; 2004 Mar; 51(3):408-14. PubMed ID: 15000372
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [General conceptions of pharmacokinetics: physiological and mathematical approaches].
    Houin G
    Ann Rech Vet; 1990; 21 Suppl 1():3S-9S. PubMed ID: 2080845
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2.
    Zhang Y; Hua Y; Benbrook DM; Covey JM; Dai G; Liu Z; Chan KK
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):561-9. PubMed ID: 16534614
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intraperitoneal carboplatin infusion may be a pharmacologically more reasonable route than intravenous administration as a systemic chemotherapy. A comparative pharmacokinetic analysis of platinum using a new mathematical model after intraperitoneal vs. intravenous infusion of carboplatin--a Sankai Gynecology Study Group (SGSG) study.
    Miyagi Y; Fujiwara K; Kigawa J; Itamochi H; Nagao S; Aotani E; Terakawa N; Kohno I;
    Gynecol Oncol; 2005 Dec; 99(3):591-6. PubMed ID: 16095677
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estimation of statistical moments and steady-state volume of distribution for a drug given by intravenous infusion.
    Chan KK; Gibaldi M
    J Pharmacokinet Biopharm; 1982 Oct; 10(5):551-8. PubMed ID: 7166738
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Basic principles and techniques of pharmacokinetic modeling.
    Riviere JE
    J Zoo Wildl Med; 1997 Mar; 28(1):3-19. PubMed ID: 9226611
    [TBL] [Abstract][Full Text] [Related]  

  • 54. On the accuracy of a one-compartment approach for determination of drug terminal half-life.
    Berezhkovskiy LM
    J Pharm Sci; 2013 Jul; 102(7):2082-4. PubMed ID: 23620272
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exact mathematical equivalence of the venous equilibration ("well-stirred") model, the sinusoidal perfusion ("parallel-tube") model, and a specific two-compartment open model.
    Wagner JG; Szpunar GJ; Ferry JJ
    Drug Metab Dispos; 1984; 12(4):385-8. PubMed ID: 6148202
    [No Abstract]   [Full Text] [Related]  

  • 56. Exploration of the African green monkey as a preclinical pharmacokinetic model: intravenous pharmacokinetic parameters.
    Ward KW; Coon DJ; Magiera D; Bhadresa S; Nisbett E; Lawrence MS
    Drug Metab Dispos; 2008 Apr; 36(4):715-20. PubMed ID: 18227143
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics and bioavailability of cefquinome in healthy piglets.
    Li XB; Wu WX; Su D; Wang ZJ; Jiang HY; Shen JZ
    J Vet Pharmacol Ther; 2008 Dec; 31(6):523-7. PubMed ID: 19000274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of azithromycin after intravenous and intramuscular administration to goats.
    Cárceles CM; Font A; Espuny A; Fernández-Varón E; Serrano JM; Escudero E
    J Vet Pharmacol Ther; 2005 Feb; 28(1):51-5. PubMed ID: 15720515
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Steady-state solutions to PBPK models and their applications to risk assessment I: Route-to-route extrapolation of volatile chemicals.
    Chiu WA; White P
    Risk Anal; 2006 Jun; 26(3):769-80. PubMed ID: 16834633
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elementary pharmacokinetics in clinical practice 2: Basic concepts of drug pharmacokinetics.
    Paxton JW
    N Z Med J; 1981 Nov; 94(695):342-5. PubMed ID: 6950264
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.